High-CBD Cannabis Shows Promise Against Postoperative Pain in Clinical Trial

A Canadian clinical trial found that patients who received a high-cannabidiol (CBD) cannabis formulation experienced significantly less moderate-to-severe chronic pain three months after knee replacement surgery compared to controls. This finding suggests CBD-dominant cannabis may offer therapeutic benefits for postoperative pain management, potentially reducing reliance on opioid medications. The study adds to growing evidence that CBD-rich formulations can modulate pain response and promote healing after surgical procedures. For Puerto Rico patients considering cannabis-based pain management options, these results highlight the importance of consulting healthcare providers about strain selection and CBD-to-THC ratios tailored to their specific conditions.